Cargando…

Pharmacokinetic analysis of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in individuals with renal impairment compared to healthy controls

Detalles Bibliográficos
Autores principales: Scheerans, Christian, Blunck, Martin, Mueck, Wolfgang, Frey, Reiner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363258/
http://dx.doi.org/10.1186/1471-2210-11-S1-P61
_version_ 1782234328307073024
author Scheerans, Christian
Blunck, Martin
Mueck, Wolfgang
Frey, Reiner
author_facet Scheerans, Christian
Blunck, Martin
Mueck, Wolfgang
Frey, Reiner
author_sort Scheerans, Christian
collection PubMed
description
format Online
Article
Text
id pubmed-3363258
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33632582012-05-31 Pharmacokinetic analysis of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in individuals with renal impairment compared to healthy controls Scheerans, Christian Blunck, Martin Mueck, Wolfgang Frey, Reiner BMC Pharmacol Poster Presentation BioMed Central 2011-08-01 /pmc/articles/PMC3363258/ http://dx.doi.org/10.1186/1471-2210-11-S1-P61 Text en Copyright ©2011 Scheerans et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Scheerans, Christian
Blunck, Martin
Mueck, Wolfgang
Frey, Reiner
Pharmacokinetic analysis of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in individuals with renal impairment compared to healthy controls
title Pharmacokinetic analysis of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in individuals with renal impairment compared to healthy controls
title_full Pharmacokinetic analysis of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in individuals with renal impairment compared to healthy controls
title_fullStr Pharmacokinetic analysis of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in individuals with renal impairment compared to healthy controls
title_full_unstemmed Pharmacokinetic analysis of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in individuals with renal impairment compared to healthy controls
title_short Pharmacokinetic analysis of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in individuals with renal impairment compared to healthy controls
title_sort pharmacokinetic analysis of the soluble guanylate cyclase activator cinaciguat (bay 58-2667) in individuals with renal impairment compared to healthy controls
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363258/
http://dx.doi.org/10.1186/1471-2210-11-S1-P61
work_keys_str_mv AT scheeranschristian pharmacokineticanalysisofthesolubleguanylatecyclaseactivatorcinaciguatbay582667inindividualswithrenalimpairmentcomparedtohealthycontrols
AT blunckmartin pharmacokineticanalysisofthesolubleguanylatecyclaseactivatorcinaciguatbay582667inindividualswithrenalimpairmentcomparedtohealthycontrols
AT mueckwolfgang pharmacokineticanalysisofthesolubleguanylatecyclaseactivatorcinaciguatbay582667inindividualswithrenalimpairmentcomparedtohealthycontrols
AT freyreiner pharmacokineticanalysisofthesolubleguanylatecyclaseactivatorcinaciguatbay582667inindividualswithrenalimpairmentcomparedtohealthycontrols